ConductScience.org, home

Paper16623765

A library of gene expression signatures to illuminate normal and pathological lymphoid biology.

Shaffer AL and 8 others. Immunol Rev, 2006. Cited by 180 papers, by iCite.

Cite this record

ConductScience Library. A library of gene expression signatures to illuminate normal and pathological lymphoid biology. Papers, record 16623765. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16623765

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A library of gene expression signatures to illuminate normal and pathological lymphoid biology.
PubMed
Journal
Immunol Rev
PubMed
Year
2006
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Review
PubMed
Citations, by iCite
180
iCite
Relative citation ratio, by iCite
2.8
iCite
Revised in PubMed
2024-12-19
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shaffer ALArthur L
2Wright GGeorge
3Yang LLiming
4Powell JJohn
5Ngo VVu
6Lamy LLaurence
7Lam LTLloyd T
8Davis RER Eric
9Staudt LMLouis M

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gene Expression ProfilingMajor topic
Gene Expression Regulation, LeukemicMajor topic
Gene LibraryMajor topic
GenomicsMajor topic
Leukemia, B-CellMajor topic
Gene Expression
Humans
Transcription Factors

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
Intramural NIH HHSUnited StatesPubMedPubMed
Z01CT000260NIHNIH RePORTER
Z01SC004024NIHNIH RePORTER
ZIACT000260NIHNIH RePORTER

Download CSV of grants

Cited by132

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 180 citations.

PMIDTitleJournalYearIn PapersSource
42595846A role for the protease MALT1 in EBV-mediated B-cell transformation by Latent Membrane Proteins 1 and 2.Leukemia2026https://conductscience.org/library/papers/42595846PubMed
42571242Alternative oncogenic drivers and sensitivity to BTK inhibition in CRISPR/Cas gene-edited human DLBCL cell models.Blood Neoplasia2026https://conductscience.org/library/papers/42571242PubMed
41591906RHOA controls oncogenic B cell receptor signaling in aggressive lymphoma.Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/41591906PubMed
40510016Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma.Am J Hematol2025https://conductscience.org/library/papers/40510016PubMed
40040873Overexpression of ornithine decarboxylase 1 mediates the immune-deserted microenvironment and poor prognosis in diffuse large B-cell lymphoma.J Natl Cancer Cent2025https://conductscience.org/library/papers/40040873PubMed
39869833Integrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody response.Blood2025https://conductscience.org/library/papers/39869833PubMed
39684518Development and Validation of a Novel Four Gene-Pairs Signature for Predicting Prognosis in DLBCL Patients.Int J Mol Sci2024https://conductscience.org/library/papers/39684518PubMed
39305307Distinct pathway activities are associated with prognosis and response to bortezomib-containing treatment in MCL1-M based molecular subtypes of multiple myeloma.Ann Hematol2024https://conductscience.org/library/papers/39305307PubMed
38701792Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas.Cancer Cell2024https://conductscience.org/library/papers/38701792PubMed
38570506Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment.Nat Commun2024https://conductscience.org/library/papers/38570506PubMed
38428430Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments.Cell Rep Med2024https://conductscience.org/library/papers/38428430PubMed
38215749Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy.Cancer Cell2024https://conductscience.org/library/papers/38215749PubMed
37600821Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma.Front Immunol2023https://conductscience.org/library/papers/37600821PubMed
37141112Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas.Cancer Discov2023https://conductscience.org/library/papers/37141112PubMed
36818048Molecular classification and therapeutics in diffuse large B-cell lymphoma.Front Mol Biosci2023https://conductscience.org/library/papers/36818048PubMed
36656933BTG1 mutation yields supercompetitive B cells primed for malignant transformation.Science2023https://conductscience.org/library/papers/36656933PubMed
36503430Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling.Mol Cancer2022https://conductscience.org/library/papers/36503430PubMed
36181613Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A.Discov Oncol2022https://conductscience.org/library/papers/36181613PubMed
36046113The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like type.Explor Target Antitumor Ther2021https://conductscience.org/library/papers/36046113PubMed
34778802Overcoming Acquired Epigenetic Resistance to BTK Inhibitors.Blood Cancer Discov2021https://conductscience.org/library/papers/34778802PubMed

See all 132 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BCL6604PubTator's text mininghttps://conductscience.org/library/genes/604NCBI Gene
MYC4609PubTator's text mininghttps://conductscience.org/library/genes/4609NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
PRDM1639PubTator's text mininghttps://conductscience.org/library/genes/639NCBI Gene
XBP17494PubTator's text mininghttps://conductscience.org/library/genes/7494NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16623765

GET https://conductscience.org/api/papers/v1/16623765/cited_by?page=2